You are here

  • Home
  • Archive
  • Volume 10, Issue 8
  • Antitumor efficacy of 90Y-NM600 targeted radionuclide therapy and PD-1 blockade is limited by regulatory T cells in murine prostate tumors

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Antitumor efficacy of 90Y-NM600 targeted radionuclide therapy and PD-1 blockade is limited by regulatory T cells in murine prostate tumors

 

Online download statistics by month:

Online download statistics by month: August 2022 to July 2025

AbstractFullPdf
Aug 202232733278
Sep 2022298310139
Oct 202222923663
Nov 202211411742
Dec 2022949520
Jan 2023929218
Feb 2023929439
Mar 2023828446
Apr 2023636531
May 202313413663
Jun 202311111217
Jul 2023939323
Aug 2023858636
Sep 2023838849
Oct 2023949628
Nov 2023616336
Dec 2023666838
Jan 2024878835
Feb 2024888934
Mar 2024646939
Apr 2024666640
May 2024545226
Jun 2024626230
Jul 2024646633
Aug 2024494673
Sep 2024586232
Oct 20249510346
Nov 2024606118
Dec 2024798232
Jan 202512512665
Feb 2025475534
Mar 2025616655
Apr 2025686934
May 2025818641
Jun 2025737318
Jul 2025110
Total340034891451